Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

329 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C, Brochet B, Berry I, Rolland Y, Froment JC, Cabanis E, Iba-Zizen MT, Gandon JM, Lai HM, Moseley I, Sabouraud O. Edan G, et al. Among authors: confavreux c. J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):112-8. doi: 10.1136/jnnp.62.2.112. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048709 Free PMC article. Clinical Trial.
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.
De Stefano N, Filippi M, Confavreux C, Vermersch P, Simu M, Sindic C, Hupperts R, Bajenaru O, Edan G, Grimaldi L, Marginean I, Medaer R, Orefice G, Pascu I, Pelletier J, Sanders E, Scarpini E, Mancardi GL. De Stefano N, et al. Among authors: confavreux c. Mult Scler. 2009 Feb;15(2):238-43. doi: 10.1177/1352458508098269. Epub 2008 Nov 5. Mult Scler. 2009. PMID: 18987103 Clinical Trial.
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller-Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D. Couturier N, et al. Among authors: confavreux c. Brain. 2011 Mar;134(Pt 3):693-703. doi: 10.1093/brain/awr010. Brain. 2011. PMID: 21354972
Geographic variations of multiple sclerosis in France.
Fromont A, Binquet C, Sauleau EA, Fournel I, Bellisario A, Adnet J, Weill A, Vukusic S, Confavreux C, Debouverie M, Clerc L, Bonithon-Kopp C, Moreau T. Fromont A, et al. Among authors: confavreux c. Brain. 2010 Jul;133(Pt 7):1889-99. doi: 10.1093/brain/awq134. Epub 2010 Jun 15. Brain. 2010. PMID: 20551111
Steroid hormones in multiple sclerosis.
El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C. El-Etr M, et al. Among authors: confavreux c. J Neurol Sci. 2005 Jun 15;233(1-2):49-54. doi: 10.1016/j.jns.2005.03.004. J Neurol Sci. 2005. PMID: 15878598 Review.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.
[New therapies in multiple sclerosis].
Roggerone S, Chenevier F, Confavreux C, Vukusic S. Roggerone S, et al. Among authors: confavreux c. Rev Prat. 2012 Oct;62(8):1057-60. Rev Prat. 2012. PMID: 23227596 French.
329 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page